ArticleScience (New York, N.Y.)2021
Resurgence of SARS-CoV-2: Detection by community viral surveillance.
Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review.European journal of epidemiology · 2022Pooled it
- Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives.International journal of pharmaceutics: X · 2026Review
- SARS-CoV-2 dynamics in New York City during March 2020-August 2023.Communications medicine · 2025Article
- Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators.PloS one · 2025Article
- Jointly estimating epidemiological dynamics of Covid-19 from case and wastewater data in Aotearoa New Zealand.Communications medicine · 2024Article
- Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.Emerging infectious diseases · 2024Article
- A Digital Mask-Voiceprint System for Postpandemic Surveillance and Tracing Based on the STRONG Strategy.Journal of medical Internet research · 2023Article
- Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.Biotech (Basel (Switzerland)) · 2023Article
- Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.PLoS medicine · 2023Observational
- Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England.Archives of disease in childhood · 2023Article
- PepGM: a probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores.Bioinformatics (Oxford, England) · 2023Article
- Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 Study.American journal of public health · 2023Article
- Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.PLoS biology · 2023Article
- Population Monitoring of SARS-CoV-2 Infections via Random Sampling During the COVID-19 Pandemic.American journal of public health · 2023Article
- Comparing the incidence of SARS-CoV-2 across age groups considering sampling biases - use of testing data of autumn 2021 in Belgium.Archives of public health = Archives belges de sante publique · 2023Article
- Article
- How time-scale differences in asymptomatic and symptomatic transmission shape SARS-CoV-2 outbreak dynamics.Epidemics · 2023Article
- Impact of climate change on SARS-CoV-2 epidemic in China.PloS one · 2023Article
- Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan.JAMA network open · 2022Article
- New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.JMIR public health and surveillance · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has mainly relied on case reporting, which is biased by health service performance, test availability, and test-seeking behaviors. We report a community-wide national representative surveillance program in England based on self-administered swab results from ~594,000 individuals tested for SARS-CoV-2, regardless of symptoms, between May and the beginning of September 2020. The epidemic declined between May and July 2020 but then increased gradually from mid-August, accelerating into early September 2020 at the start of the second wave. When compared with cases detected through routine surveillance, we report here a longer period of decline and a younger age distribution. Representative community sampling for SARS-CoV-2 can substantially improve situational awareness and feed into the public health response even at low prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.